2016
DOI: 10.1002/ange.201604193
|View full text |Cite
|
Sign up to set email alerts
|

Evaluierung neuer Reaktionen zur Steuerung der Wirkstoff‐Forschung: ein Eignungstest

Abstract: Mit der Verbesserung unserer Kenntnisse zur Bedeutung bestimmter Moleküleigenschaften bei Anwendungen im Rahmen der Wirkstoffsuche wird das Ausmaß immer klarer, in dem veröffentlichte Synthesemethoden erwünschten Kriterien genügen (oder nicht genügen). Wir beschreiben hier, wie die Anwendung einfacher (und in vielen Fällen frei verfügbarer) Rechenprogramme genutzt werden kann, um ein semiquantitatives Verständnis des Potenzials von neuen Methoden in der Wirkstoff‐Forschung zu entwickeln. Diese Analyse kann sic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 17 publications
(1 citation statement)
references
References 73 publications
(38 reference statements)
0
1
0
Order By: Relevance
“…Modern drug discovery has been changing rapidly with terms scaffold hopping, [1] escape the flatland, [2] and conformational restriction, [3] emerging,a nd has gained great recognition in the scientific community.I nt his context chemists are currently looking for novel three-dimensionally (3D) shaped Fsp 3 -rich building blocks. [4,5] In 2010, Müller, Carreira, and co-workers demonstrated the high potential of azaspirocycles as building blocks for drug discovery.…”
mentioning
confidence: 99%
“…Modern drug discovery has been changing rapidly with terms scaffold hopping, [1] escape the flatland, [2] and conformational restriction, [3] emerging,a nd has gained great recognition in the scientific community.I nt his context chemists are currently looking for novel three-dimensionally (3D) shaped Fsp 3 -rich building blocks. [4,5] In 2010, Müller, Carreira, and co-workers demonstrated the high potential of azaspirocycles as building blocks for drug discovery.…”
mentioning
confidence: 99%